Detalles de la búsqueda
1.
Development of a Pan-H1 Influenza Vaccine.
J Virol
; 92(22)2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30185594
2.
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.
Sci Transl Med
; 14(643): eabf3685, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507671
3.
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
Sci Transl Med
; 13(583)2021 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33658355
4.
Comparison of adjuvants to optimize influenza neutralizing antibody responses.
Vaccine
; 37(42): 6208-6220, 2019 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493950
5.
Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.
Hum Vaccin Immunother
; 13(12): 2996-3009, 2017 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933684
6.
Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).
J Immunol Methods
; 301(1-2): 21-30, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15894326
7.
Application of the polyvalent approach to HIV-1 vaccine development.
Curr Drug Targets Infect Disord
; 5(2): 143-56, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15975020
8.
Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice.
World J Gastroenterol
; 11(29): 4583-6, 2005 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16052693
9.
Gene delivery using physical methods: an overview.
Methods Mol Biol
; 245: 147-66, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14707376
10.
The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
Vaccine
; 26(40): 5145-52, 2008 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-18462847
11.
Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates.
Curr HIV Res
; 6(4): 296-305, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691028
12.
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
Virology
; 371(1): 98-107, 2008 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17950773
13.
Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen.
Virology
; 355(2): 164-74, 2006 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-16919703
14.
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
Vaccine
; 24(21): 4531-40, 2006 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-16140431
15.
Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Virology
; 346(1): 151-68, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16325880
16.
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Virology
; 350(1): 34-47, 2006 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16616287
17.
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
Virology
; 348(2): 341-53, 2006 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16460776
18.
Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.
J Virol
; 79(3): 1906-10, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15650214
19.
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.
J Virol
; 79(12): 7933-7, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15919951
20.
Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Virology
; 334(1): 134-43, 2005 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-15749129